AuntMinnie.com staff writersRadiation Oncology/TherapyRadical Catheter Technologies gets FDA clearance for 6F catheter6F is the company's third FDA-cleared catheter.April 13, 2026Radiation Oncology/TherapySirtex reports that DOORwaY90 study shows 100% tumor control for HCCThe results were presented in an oral presentation at the Society of Interventional Radiology Annual Meeting in Toronto.April 13, 2026Patient SafetyFDA reminds sponsors, researchers to disclose clinical trial resultsStudies subject to mandatory reporting include interventional studies with a U.S. nexus and an FDA-regulated product that are past the deadline to report.April 13, 2026InterventionalMicrobot Medical launches Liberty robotic system nationwideLiberty has been used commercially across a range of procedures.April 13, 2026AssociationsARRS honors Kruskal, Katz with 2026 Gold MedalThe American Roentgen Ray Society (ARRS) has awarded its highest honor to Jonathan Kruskal, MB, ChB, PhD, and Douglas Katz, MD.April 13, 2026Radiation Oncology/TherapyNational Proton Conference highlights phase III trial dataData supports survival benefit for intensity-modulated proton therapy (IMPT) in head and neck cancer.April 10, 2026Risk ManagementMRI accident investigation continues, lawsuit filedNext episode of "The Invisible Force" podcast coming soon.April 10, 2026NeuroradiologyFDA accepts Telix NDA for glioma PET agent PixclaraThe NDA resubmission included additional data and statistical analysis requested by the U.S. FDA.April 10, 2026Radiation Oncology/TherapyASRT recognizes award-winning radiation therapy team projectsASRTProject results include decreased RT appointment cancellations and improved patient satisfaction ratings.April 10, 2026Nuclear MedicineShine receives $263M conditional loan for Mo-99 isotope facilityShine has received a conditional loan from the U.S. DOE to complete the Chrysalis medical isotope production facility for Mo-99.April 9, 2026Page 1 of 251Next PageTop StoriesMolecular ImagingARRS: Do GLP-1 drugs confound FDG-PET imaging scans?No significant differences in FDG uptake were observed in the skeletal muscle, liver, blood pool, or abdominal fat following GLP-1 agonist therapy.AIFDA strikes down radiology AI 510(k) exemption argumentsWomens ImagingARRS: How should breast imagers develop surveillance strategies?CTPopulation-level lung cancer rate higher than NLST rateInterventionalStent therapy effective for post-thrombotic syndrome
